tiprankstipranks
Bio-Key International (BKYI)
OTHER OTC:BKYI
US Market
Want to see BKYI full AI Analyst Report?

BIO-key International (BKYI) Price & Analysis

503 Followers

BKYI Stock Chart & Stats

$0.88
-$0.29(-17.16%)
At close: 4:00 PM EST
$0.88
-$0.29(-17.16%)

Bulls Say, Bears Say

Bulls Say
Financial PerformanceManagement continues to expect sequential revenue growth and improved profitability in 2025.
Product InnovationBKYI recently entered the passkey authentication market with the launch of 'Passkey:YOU', a unique password-less authentication solution.
Sales StrategyBKYI is building a military- and intelligence-focused global sales team targeting the growing EU defense opportunity.
Bears Say
Brand Strategy ShiftResults were below expectations due to an intentional shift away from its Swivel Secure brand to focus on core Bio-Key branded solutions.

BIO-key International News

BKYI FAQ

What was Bio-Key International’s price range in the past 12 months?
Bio-Key International lowest stock price was $3.10 and its highest was $19.70 in the past 12 months.
    What is Bio-Key International’s market cap?
    Bio-Key International’s market cap is $5.15M.
      When is Bio-Key International’s upcoming earnings report date?
      Bio-Key International’s upcoming earnings report date is Aug 17, 2026 which is in 85 days.
        How were Bio-Key International’s earnings last quarter?
        Currently, no data Available
        Is Bio-Key International overvalued?
        According to Wall Street analysts Bio-Key International’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Bio-Key International pay dividends?
          Bio-Key International does not currently pay dividends.
          What is Bio-Key International’s EPS estimate?
          Bio-Key International’s EPS estimate is -0.8.
            How many shares outstanding does Bio-Key International have?
            Bio-Key International has 1,085,212 shares outstanding.
              What happened to Bio-Key International’s price movement after its last earnings report?
              Currently, no data Available
              Which hedge fund is a major shareholder of Bio-Key International?
              Currently, no hedge funds are holding shares in BKYI
              What is the TipRanks Smart Score and how is it calculated?
              Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                Company Description

                Bio-Key International

                BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform. Its solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and Civil and Large-Scale ID Infrastructure solutions that develops finger-based biometric technology. Further, it offers finger scanners for enterprise and consumer markets under SideSwipe, EcoID, and SidePass brand names. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey.

                BIO-key International (BKYI) Earnings & Revenues

                BKYI Earnings Call

                Q1 2026
                0:00 / 0:00
                Earnings Call Sentiment|Positive
                The call conveyed meaningful operational and financial progress: strong top-line growth (+34%), higher-margin license expansion (+24%), a >100% rise in hardware revenue, a 33% increase in gross profit and a large reduction in net loss (≈77.6%). Management highlighted expanding global partnerships (notably TD Synnex/DLT), an improving pipeline with larger deals, and guidance toward profitability and positive cash flow in Q2. Key risks discussed include a recent NASDAQ suspension (appeal pending), prior delinquent filings that management is remediating, a quarter-over-quarter cash decline, and some lumpy/one-time inventory-driven hardware sales. On balance, the positives (growth, margins, partnerships, improved profitability outlook) significantly outweigh the operational and listing-related negatives.View all BKYI earnings summaries
                Similar Stocks
                Company
                Price & Change
                Follow
                SuperCom
                Iveda Solutions
                VerifyMe
                Knightscope Inc Class A

                Ownership Overview

                37.08%7.83%51.88%
                37.08% Insiders
                ― Other Institutional Investors
                51.88% Public Companies and
                Individual Investors

                Options Prices

                Currently, No data available
                ---
                Popular Stocks